BODENSTEDT MATTHIAS (Chief Financial Officer) sold 3.4% of their position (39.12K shares) of MOONLAKE IMMUNOTHERAPEUTICS on the open market
Open‑market sale worth $862.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/23/2026ACC: 0001213900-26-071075
Officer· Chief Financial Officer
Since Apr 2022
-39.12K
Net shares
Net seller
$862.2K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
39.12K disposed
Non-Derivative Transactions1
Class A ordinary shares, par value $0.0001 per share
Direct
Shares
−39.12K
Price / share
$22.04
Trade value
$862.20K
% of position
3.4%
6/22/2026
1.15M→1.12M
Total
Net shares
−39.12K
Net value
-$862.20K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A ordinary shares, par value $0.0001 per share Direct | 6/22/2026 | S · Sale | −39.12K | $22.04 | $862.20K | 3.4% | 1.15M | 1.12M |
| Total | −39.12K | -$862.20K | ||||||
Derivative Transactions0
No derivative transactions reported